Pacific Biosciences of California (PACB) Short Interest Ratio & Short Volume $1.54 -0.10 (-6.10%) Closing price 02/21/2025 04:00 PM EasternExtended Trading$1.54 -0.01 (-0.32%) As of 02/21/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Pacific Biosciences of California Short Interest DataPacific Biosciences of California (PACB) has a short interest of 60.40 million shares. This marks a -0.23% decrease in short interest from the previous month. The short interest ratio (days to cover) is 5.7, indicating that it would take 5.7 days of the average trading volume of 13.49 million shares to cover all short positions.Current Short Interest60,400,000 sharesPrevious Short Interest60,540,000 sharesChange Vs. Previous Month-0.23%Dollar Volume Sold Short$93.02 millionShort Interest Ratio5.7 Days to CoverLast Record DateJanuary 31, 2025Outstanding Shares273,860,000 sharesPercentage of Shares Shorted22.06%Today's Trading Volume13,051,555 sharesAverage Trading Volume13,485,142 sharesToday's Volume Vs. Average97% Short Selling Pacific Biosciences of California? Sign up to receive the latest short interest report for Pacific Biosciences of California and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartPACB Short Interest Over TimePACB Days to Cover Over TimePACB Percentage of Float Shorted Over Time Pacific Biosciences of California Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 1/31/202560,400,000 shares $93.02 million -0.2%N/A5.7 $1.54 1/15/202560,540,000 shares $105.64 million +6.5%N/A6 $1.75 12/31/202456,850,000 shares $104.04 million +7.1%N/A5.8 $1.83 12/15/202453,060,000 shares $104.00 million -2.4%N/A5.7 $1.96 11/30/202454,380,000 shares $103.87 million +4.3%N/A5.6 $1.91 11/15/202452,140,000 shares $83.16 million +3.4%N/A5.5 $1.60 10/31/202450,410,000 shares $109.39 million +3.9%N/A5.8 $2.17 10/15/202448,540,000 shares $101.93 million -6.0%N/A5.9 $2.10 9/30/202451,640,000 shares $87.79 million +11.0%N/A5.7 $1.70 9/15/202446,530,000 shares $84.22 million -23.8%N/A4.9 $1.81 Get the Latest News and Ratings for PACB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Pacific Biosciences of California and its competitors with MarketBeat's FREE daily newsletter. 8/31/202461,030,000 shares $83.61 million +1.8%N/A6.8 $1.37 8/15/202459,960,000 shares $101.33 million +5.0%N/A6.8 $1.69 7/31/202457,100,000 shares $117.63 million -7.4%N/A5.9 $2.06 7/15/202461,680,000 shares $99.92 million +9.2%N/A6.2 $1.62 6/30/202456,470,000 shares $77.36 million +3.5%N/A5.3 $1.37 6/15/202454,570,000 shares $96.04 million +0.6%N/A5.3 $1.76 5/31/202454,250,000 shares $97.11 million -4.1%N/A5.2 $1.79 5/15/202456,580,000 shares $121.36 million +7.1%N/A5.2 $2.15 4/30/202452,820,000 shares $87.15 million +8.9%N/A5.1 $1.65 4/15/202448,520,000 shares $137.55 million -1.1%N/A5 $2.84 3/31/202449,050,000 shares $183.94 million +7.6%N/A5.6 $3.75 3/15/202445,570,000 shares $172.71 million +4.7%N/A5.4 $3.79 2/29/202443,540,000 shares $240.78 million +7.8%N/A5.3 $5.53 2/15/202440,380,000 shares $269.33 million +18.1%N/A5.4 $6.67 1/31/202434,190,000 shares $222.58 million -5.0%N/A5.1 $6.51 1/15/202436,000,000 shares $241.56 million -4.7%N/A5.6 $6.71 12/31/202337,780,000 shares $370.62 million +8.3%N/A6.7 $9.81 12/15/202334,890,000 shares $329.36 million +4.4%N/A6.7 $9.44 11/30/202333,430,000 shares $283.49 million -14.8%N/A7 $8.48 11/15/202339,230,000 shares $306.39 million +11.7%N/A8.5 $7.81 10/31/202335,120,000 shares $217.04 million -6.9%N/A8.1 $6.18 10/15/202337,740,000 shares $301.17 million +14.1%N/A9.6 $7.98 9/30/202333,070,000 shares $276.13 million -2.2%N/A8.6 $8.35 9/15/202333,820,000 shares $352.40 million +2.3%N/A9.4 $10.42 8/31/202333,060,000 shares $372.92 million +5.3%N/A9.3 $11.28 8/15/202331,390,000 shares $352.20 million +10.6%N/A8.3 $11.22 7/31/202328,390,000 shares $375.03 million -7.6%N/A7.7 $13.21 7/15/202330,710,000 shares $421.96 million -2.7%N/A8.6 $13.74 6/30/202331,550,000 shares $419.62 million +25.3%N/A8.8 $13.30 6/15/202325,190,000 shares $335.28 million -1.0%N/A6.7 $13.31Has Trump finally met his match? (Ad)Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance to walk away with gains as high as 235%, 459%, and 700% - all while the stock market got cut in half. Could he be right again?Click here for his emergency broadcast... 5/31/202325,440,000 shares $314.95 million +5.2%N/A6.7 $12.38 5/15/202324,180,000 shares $300.80 million -5.0%N/A6.6 $12.44 4/30/202325,440,000 shares $269.66 million -6.4%N/A6.7 $10.60 4/15/202327,180,000 shares $304.42 million +8.3%N/A6.6 $11.20 3/31/202325,100,000 shares $290.66 million -4.5%N/A5.8 $11.58 3/15/202326,280,000 shares $238.10 million +14.2%N/A6.2 $9.06 2/28/202323,020,000 shares $209.02 million +8.4%N/A5.6 $9.08 2/15/202321,240,000 shares $235.55 million -5.6%N/A5.3 $11.09 1/31/202322,490,000 shares $249.41 million -7.1%N/A5 $11.09 1/15/202324,200,000 shares $265.23 million -1.9%N/A4.9 $10.96 12/30/202224,670,000 shares $201.80 million +8.1%N/A5.1 $8.18 12/15/202222,820,000 shares $206.75 million +3.8%N/A4.4 $9.06 11/30/202221,990,000 shares $236.39 million -9.1%N/A3.9 $10.75 11/15/202224,190,000 shares $270.93 million +4.1%N/A4 $11.20 10/31/202223,240,000 shares $196.15 million -3.0%N/A3 $8.44 10/15/202223,950,000 shares $146.10 million -5.3%N/A3.1 $6.10 9/30/202225,290,000 shares $146.81 million -16.6%N/A3.3 $5.81 9/15/202230,310,000 shares $200.35 million +4.8%N/A3.8 $6.61 8/31/202228,930,000 shares $169.53 million -11.6%N/A3.6 $5.86 8/15/202232,720,000 shares $273.54 million -7.5%N/A3.9 $8.36 7/31/202235,360,000 shares $154.52 million -1.9%N/A5.1 $4.37 7/15/202236,030,000 shares $152.77 million -12.2%N/A5.1 $4.24 6/30/202241,020,000 shares $181.31 million +7.9%N/A5.7 $4.42 6/15/202238,010,000 shares $162.68 million +10.6%N/A5.3 $4.28 5/31/202234,370,000 shares $193.50 million +3.0%N/A5 $5.63 5/15/202233,370,000 shares $194.88 million +1.2%N/A5.2 $5.84 4/30/202232,960,000 shares $208.97 million +8.8%N/A5.5 $6.34 4/15/202230,290,000 shares $228.39 million -2.8%N/A5.2 $7.54 3/31/202231,170,000 shares $283.65 million +1.3%N/A5.6 $9.10 3/15/202230,760,000 shares $281.76 million +3.5%N/A6.3 $9.16 2/28/202229,710,000 shares $354.14 million +8.5%N/A6.6 $11.92 2/15/202227,390,000 shares $311.70 million +3.1%N/A6.3 $11.38 1/31/202226,580,000 shares $297.16 million +22.9%N/A7.1 $11.18 1/15/202221,630,000 shares $268.86 million +8.6%N/A6.9 $12.43 12/31/202119,910,000 shares $407.36 million -1.6%N/A7.8 $20.46 12/15/202120,230,000 shares $444.86 million +19.2%N/A9 $21.99 11/30/202116,970,000 shares $393.87 million -5.1%N/A8.5 $23.21 11/15/202117,890,000 shares $477.66 million +0.9%N/A9.6 $26.70 10/29/202117,730,000 shares $469.49 million +14.2%9.3%9.9 $26.48 10/15/202115,520,000 shares $378.53 million +9.3%8.2%8.5 $24.39 9/30/202114,200,000 shares $362.81 million +9.3%7.5%7.4 $25.55 9/15/202112,990,000 shares $359.04 million +2.4%6.8%6.6 $27.64 8/31/202112,690,000 shares $397.32 million +8.8%6.7%6.4 $31.31 8/13/202111,660,000 shares $343.62 million -2.1%6.1%5.7 $29.47 7/30/202111,910,000 shares $382.91 million -2.6%6.3%5.2 $32.15 7/15/202112,230,000 shares $330.21 million -10.5%6.5%5 $27.00 6/30/202113,660,000 shares $477.69 million -0.8%7.2%5.5 $34.97 6/15/202113,770,000 shares $385.84 million +0.8%7.3%5.2 $28.02 5/28/202113,660,000 shares $369.50 million -2.6%7.2%4.7 $27.05 5/14/202114,030,000 shares $312.87 million +3.1%N/A3.9 $22.30Nvidia’s CEO: “This Will Be a Multitrillion-Dollar Industry." (Ad)If you missed out on the big boom in Nvidia… Listen up, because according to Nvidia's own CEO… Elon Musk’s new technology could help launch an entirely new multitrillion-dollar industry.You MUST act before March 17th. 4/30/202113,610,000 shares $455.66 million +15.9%N/A3.2 $33.48 4/15/202111,740,000 shares $382.14 million -8.9%N/A2.8 $32.55 3/31/202112,890,000 shares $386.06 million +12.4%N/A2.7 $29.95 3/15/202111,470,000 shares $388.72 million +28.9%N/A2.1 $33.89 2/26/20218,900,000 shares $277.46 million -8.3%N/A1.6 $31.18 2/12/20219,710,000 shares $496.67 million -25.3%N/A1.9 $51.15 1/29/202113,000,000 shares $445.64 million -1.2%N/A2.7 $34.28 1/15/202113,160,000 shares $496.40 million -15.7%N/A2.7 $37.72 12/31/202015,610,000 shares $411.32 million +30.7%N/A3.2 $26.35 12/15/202011,940,000 shares $249.55 million -12.8%N/A2.6 $20.90 11/30/202013,690,000 shares $211.24 million -5.1%N/A3.1 $15.43 11/15/202014,430,000 shares $241.56 million -3.7%N/A3.4 $16.74 10/30/202014,990,000 shares $200.27 million -14.0%N/A3.5 $13.36 10/15/202017,420,000 shares $243.18 million +0.2%N/A4.5 $13.96 9/30/202017,380,000 shares $171.54 million +0.9%N/A5.3 $9.87 9/15/202017,230,000 shares $126.12 million +3.8%N/A7 $7.32 8/31/202016,600,000 shares $109.56 million -4.8%N/A8.3 $6.60 8/14/202017,430,000 shares $100.22 million +0.1%12.3%9.9 $5.75 7/31/202017,410,000 shares $64.94 million -2.4%12.3%13.7 $3.73 7/15/202017,830,000 shares $74.35 million -0.1%12.6%14.2 $4.17 6/30/202017,850,000 shares $61.58 million +11.1%12.6%13.6 $3.45 6/15/202016,070,000 shares $59.46 million -1.2%11.4%11.2 $3.70 5/29/202016,270,000 shares $57.27 million -1.6%11.5%9.9 $3.52 5/15/202016,540,000 shares $57.56 million -7.6%11.7%8.5 $3.48 4/30/202017,890,000 shares $63.33 million -0.9%12.6%7.6 $3.54 4/15/202018,050,000 shares $50.54 million -1.6%13.0%7.9 $2.80 3/31/202018,350,000 shares $59.09 million -13.7%13.2%7.1 $3.22 3/13/202021,266,400 shares $61.67 million +19.1%15.3%7.7 $2.90 2/28/202017,860,000 shares $50.37 million +9.6%12.8%6.9 $2.82 PACB Short Interest - Frequently Asked Questions What is Pacific Biosciences of California's current short interest? Short interest is the volume of Pacific Biosciences of California shares that have been sold short but have not yet been covered or closed out. As of January 31st, traders have sold 60,400,000 shares of PACB short. Learn More on Pacific Biosciences of California's current short interest. What is a good short interest ratio for Pacific Biosciences of California? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. PACB shares currently have a short interest ratio of 6.0. Learn More on Pacific Biosciences of California's short interest ratio. Which institutional investors are shorting Pacific Biosciences of California? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Pacific Biosciences of California: GTS Securities LLC, Wolverine Trading LLC, Squarepoint Ops LLC, Group One Trading LLC, Citadel Advisors LLC, Jane Street Group LLC, Concourse Financial Group Securities Inc., Walleye Trading LLC, and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Pacific Biosciences of California's short interest increasing or decreasing? Pacific Biosciences of California saw a decrease in short interest during the month of January. As of January 31st, there was short interest totaling 60,400,000 shares, a decrease of 0.2% from the previous total of 60,540,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Pacific Biosciences of California's short interest compare to its competitors? Here is how the short interest of companies compare to Pacific Biosciences of California: Harvard Bioscience, Inc. (1.74%), Thermo Fisher Scientific Inc. (1.04%), Agilent Technologies, Inc. (1.15%), Mettler-Toledo International Inc. (1.98%), Waters Co. (2.70%), Illumina, Inc. (4.11%), Bio-Techne Co. (2.50%), Charles River Laboratories International, Inc. (3.91%), Bio-Rad Laboratories, Inc. (3.05%), Bruker Co. (6.56%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.21 billion), Charter Communications, Inc. ($4.07 billion), Reddit, Inc. ($3.33 billion), The Kroger Co. ($2.67 billion), Cencora, Inc. ($2.29 billion), Hims & Hers Health, Inc. ($2.17 billion), SoFi Technologies, Inc. ($1.99 billion), Live Nation Entertainment, Inc. ($1.87 billion), Rivian Automotive, Inc. ($1.76 billion), and Moderna, Inc. ($1.60 billion). View all of the most shorted stocks. What does it mean to sell short Pacific Biosciences of California stock? Short selling PACB is an investing strategy that aims to generate trading profit from Pacific Biosciences of California as its price is falling. PACB shares are trading down $0.10 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Pacific Biosciences of California? A short squeeze for Pacific Biosciences of California occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of PACB, which in turn drives the price of the stock up even further. How often is Pacific Biosciences of California's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PACB, twice per month. The most recent reporting period available is January, 31 2025. More Short Interest Resources from MarketBeat Related Companies Harvard Bioscience Short Squeeze Thermo Fisher Scientific Short Squeeze Agilent Technologies Short Squeeze Mettler-Toledo International Short Squeeze Waters Short Squeeze Illumina Short Squeeze Bio-Techne Short Squeeze Charles River Laboratories International Short Squeeze Bio-Rad Laboratories Short Squeeze Bruker Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:PACB) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | Sponsored[RFK Jr CONFIRMED] Here’s why Dems are TERRIFIEDRobert F. Kennedy Jr was just confirmed as Trump’s secretary of Health and Human Services… but it was NOT easy...NewMarket Health Publishing, LLC. | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | SponsoredWe recommended Palantir in 2021, now we’re recommending this...I believe it could offer you a MAJOR boost to your retirement. And it pays huge dividends to give you a nic...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pacific Biosciences of California, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Pacific Biosciences of California With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PACB Stock Alerts